Carlsmed, Inc. Selling Expense
Carlsmed, Inc. (CARL) reported Selling Expense of $9.16 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:SellingExpense · last filed 2026-08-05
- Carlsmed, Inc. selling expense for the quarter ending 2026-06-30 was $9.16M, a 51.91% increase year-over-year.
- Carlsmed, Inc. selling expense for the quarter ending 2026-03-31 was $7.88M, a 57.26% increase year-over-year.
- Carlsmed, Inc. selling expense for the quarter ending 2025-12-31 was $8.38M, a 65.59% increase year-over-year.
- Carlsmed, Inc. selling expense for the quarter ending 2025-09-30 was $7.00M, a 63.13% increase year-over-year.
- Carlsmed, Inc. selling expense for fiscal 2025 was $26.43M, a 69.94% increase from fiscal 2024.
- Carlsmed, Inc. selling expense for fiscal 2024 was $15.55M.
| Period end | Selling Expense 3 month | Selling Expense 6 month | Selling Expense 9 month | Selling Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $9.16M 10-Q · filed 2026-08-05 | $17.04M 10-Q · filed 2026-08-05 | $25.42M derived: sum of 3 quarters · filed 2026-08-05 | $32.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $7.88M 10-Q · filed 2026-05-05 | $16.26M derived: sum of 2 quarters · filed 2026-05-05 | $23.27M derived: sum of 3 quarters · filed 2026-05-05 | $29.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $8.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $15.38M derived: sum of 2 quarters · filed 2026-02-25 | $21.41M derived: sum of 3 quarters · filed 2026-08-05 | $26.43M 10-K · filed 2026-02-25 |
| 2025-09-30 | $7.00M 10-Q · filed 2025-11-06 | $13.03M derived: sum of 2 quarters · filed 2026-08-05 | $18.05M 10-Q · filed 2025-11-06 | $23.11M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $6.03M 10-Q · filed 2026-08-05 | $11.04M 10-Q · filed 2026-08-05 | $16.10M derived: sum of 3 quarters · filed 2026-08-05 | $20.40M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $5.01M 10-Q · filed 2026-05-05 | $10.07M derived: sum of 2 quarters · filed 2026-05-05 | $14.37M derived: sum of 3 quarters · filed 2026-05-05 | $17.80M derived: sum of 4 quarters · filed 2026-05-05 |
| 2024-12-31 | $5.06M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | $9.35M derived: sum of 2 quarters · filed 2026-02-25 | $12.79M derived: sum of 3 quarters · filed 2026-02-25 | $15.55M 10-K · filed 2026-02-25 |
| 2024-09-30 | $4.29M 10-Q · filed 2025-11-06 | $7.73M derived: sum of 2 quarters · filed 2025-11-06 | $10.49M 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $3.43M 10-Q · filed 2025-08-28 | $6.20M 10-Q · filed 2025-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| NeuroPace Inc (NPCE) | United States | $0.480B | -28.52 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |